|
Acelyrin
|
17/05
|
4,39
|
-5,18%
|
4,67
|
4,37 - 4,68
|
|
Achari Ventures Holdings Corp. I
|
08/04
|
10,93
|
0,00%
|
10,93
|
10,93 - 10,93
|
|
Achari Ventures Holdings Corp. I Units Cons Of 1 Sh +
|
04/03
|
12,03
|
0,00%
|
0
|
---
|
|
Achari Ventures Holdings Corp. I Warrant 2021-
|
08/04
|
0,0221
|
0,00%
|
0,0221
|
0,0221 - 0,0221
|
|
Achieve Life Sciences
|
17/05
|
5
|
-1,38%
|
5,01
|
4,91 - 5,08
|
|
Achilles Therapeutics Plc Sponsored Adr
|
17/05
|
0,9478
|
+3,57%
|
0,9271
|
0,9026 - 0,96
|
|
Aci Worldwide
|
17/05
|
37,53
|
+1,60%
|
37,14
|
37 - 37,59
|
|
Aclarion
|
17/05
|
0,3245
|
-1,07%
|
0,3247
|
0,31 - 0,3499
|
|
Aclarion, Inc. Warrant 2022- On Aclarion
|
17/05
|
0,03
|
-14,29%
|
0,03
|
0,0299 - 0,03
|
|
Aclaris Therapeutics
|
17/05
|
1,19
|
+0,85%
|
1,2
|
1,15 - 1,2
|
|
Acm Research
|
17/05
|
23,8
|
-2,82%
|
24,46
|
23,7401 - 24,97
|
|
Acnb
|
17/05
|
33,92
|
+0,03%
|
34,09
|
33,89 - 34,785
|
|
Acorda Therapeutics
|
11/04
|
0,661
|
0,00%
|
0,661
|
0,661 - 0,661
|
|
Acorq
|
11/04
|
0,661
|
0,00%
|
0,661
|
0,661 - 0,661
|
|
Acri Capital Acquisition
|
17/05
|
11,22
|
-0,62%
|
11,22
|
11,22 - 11,22
|
|
Acri Capital Acquisition Corporation Units Cons Of
|
03/05
|
11,65
|
0,00%
|
0
|
---
|
|
Acri Capital Acquisition Corporation Warrant 2022- On
|
01/05
|
0,07
|
0,00%
|
0
|
---
|
|
Acrivon Therapeutics
|
17/05
|
8,89
|
+3,86%
|
8,57
|
8,565 - 9
|
|
Actelis Networks
|
17/05
|
0,521
|
+1,96%
|
0,5308
|
0,5 - 0,54
|
|
Acumen Pharmaceuticals
|
17/05
|
3,65
|
-2,14%
|
3,74
|
3,56 - 3,7669
|